Project Alleviation of proteasomal inhibition as a therapeutic approach for SCA3

Basic data

Title:
Alleviation of proteasomal inhibition as a therapeutic approach for SCA3
Duration:
01/01/2017 to 31/12/2017
Abstract / short description:
The project deals with the analysis of protein degradation mechanisms and their therapeutic potential for a neurodegenerative disorder (Spinocerebellar Ataxia Type 3).
Keywords:
neurodegenerative disorder
neurodegenerative Erkrankung
proteins
Proteine
therapies
Therapien

Involved staff

Managers

Faculty of Medicine
University of Tübingen

Local organizational units

Institute of Medical Genetics and Applied Genomics
Department of Diagnostic Laboratory Medicine
Hospitals and clinical institutes, Faculty of Medicine

Funders

Minneapolis, Minnesota, United States of America
Help

will be deleted permanently. This cannot be undone.